Pharmaceutical Lipids Industry to Reach USD 8.04 Billion by 2033 at a 5.0% CAGR

The global pharmaceutical lipids market is poised for steady growth, projected to expand from USD 4.93 billion in 2023 to USD 8.04 billion by 2033, at a compound annual growth rate (CAGR) of 5.0% over the forecast period. This growth is driven by the expanding pharmaceutical industry, which leverages lipids as critical components for energy …

Compression Therapy Industry to Reach USD 5,925.20 Million by 2034 at a 5.8% CAGR

The global compression therapy market is on a steady growth trajectory, with revenue estimated at USD 3,371.70 million in 2024 and projected to reach USD 5,925.20 million by 2034. This expansion represents a compound annual growth rate (CAGR) of 5.8% over the forecast period, driven by increased demand for advanced treatments and rehabilitation solutions. Key …

Superficial Radiation Therapy System Industry to Grow at 3.8% CAGR, Valued at USD 58.2 million in 2030

The global superficial radiation therapy (SRT) system market is poised for positive growth, with a market valuation of USD 43.3 million recorded in 2022. The market is projected to expand at a compound annual growth rate (CAGR) of 3.8% over the forecast period, reflecting steady growth driven by increasing demand for non-invasive treatments for skin …

COVID-19 Diagnostics Industry Driven by Innovations in Testing Technologies and Expanding Local Production

The COVID-19 diagnostics market continues to evolve rapidly as industry players focus on developing highly sensitive and specific testing kits to address global demand. Reverse Transcription Polymerase Chain Reaction (RT-PCR) remains the gold standard for COVID-19 diagnosis, being the most widely used diagnostic method worldwide due to its high accuracy and reliability. Leading market players …

Preparative and Process Chromatography Industry to Reach USD 14.53 Billion by 2034 at 3.9% CAGR

The global preparative and process chromatography market is set to grow from USD 9.93 billion in 2024 to USD 14.53 billion by 2034, expanding at a compound annual growth rate (CAGR) of 3.9%. This growth is driven by the rising demand for monoclonal antibodies and their growing adoption in the pharmaceutical and biotechnology sectors, alongside …

Manual Resuscitator Industry to Reach USD 1,204.3 Million by 2034 at 6.4% CAGR

The global manual resuscitator market is projected to grow from USD 647.6 million in 2024 to USD 1,204.3 million by 2034, reflecting a compound annual growth rate (CAGR) of 6.4% during the forecast period. Despite competition from automatic resuscitators, manual resuscitators remain a vital piece of equipment in hospitals worldwide, particularly in resource-constrained settings. Automatic …

Orthopedic Braces and Support Industry to Double by 2034, Surpassing USD 8.8 Billion at 6.7% CAGR

The global orthopedic braces and support market is projected to experience robust growth over the next decade, with its valuation anticipated to grow from USD 4.6 billion in 2024 to USD 8.8 billion by 2034, representing a compound annual growth rate (CAGR) of 6.7% during the assessment period. The increasing prevalence of musculoskeletal disorders, sports …

Automated Cell Culture Systems Industry to Surpass USD 43,334.5 Million by 2035, Growing at 9.1% CAGR

The global automated cell culture systems market is projected to grow at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2035, increasing from an estimated USD 18,074.5 million in 2025 to USD 43,334.5 million by 2035. This significant growth is driven by the increasing adoption of automation in biopharmaceutical manufacturing and drug …

Oligonucleotide API Industry to Reach USD 4.84 Billion by 2034 at 5.60% CAGR

The global oligonucleotide API market is poised for significant growth, with demand projected to rise at a robust compound annual growth rate (CAGR) of 5.6% from 2024 to 2034. The market, valued at USD 2.81 billion in 2024, is anticipated to reach USD 4.84 billion by the end of 2034, driven by the growing need …

Vaginitis Treatment Drug Industry to Reach USD 5,230 Million by 2034, Growing at 4.8% CAGR

The global vaginitis treatment drug market is projected to grow steadily, expanding from USD 3,328.9 million in 2024 to USD 5,320 million by 2034, at a compound annual growth rate (CAGR) of 4.8%. This growth is driven by increasing awareness of women’s health, rising prevalence of vaginitis, and heightened demand for effective treatments for bacterial …